Scholar Applications

The Taubman Scholars is the core program of the Taubman Institute, providing University of Michigan senior physician-scientists with financial support designed to foster translational research. The goal of the program is to accelerate the pace with which laboratory discoveries are transformed into new patient treatments.

Taubman Scholars receive grants of $150,000 per year for three years. Although the Taubman Institute provides grants for research on a wide spectrum of diseases, it has core areas of inquiry: cancer, cardiovascular disease, diabetes and other metabolic diseases, and neurological disorders. It has recently expanded its focus to include childhood muscle diseases. It also seeks to fund scientists working in the emerging technologies of advanced imaging and surgical devices, who will collaborate with other Scholars to allow for the rapid translation of new ideas into actual therapies.

A call for applications has been issued for the next cohort of Scholars, whose term will begin on July 1, 2014. The deadline for applications is December 1, 2013.

Eligibility is restricted to:

  • University of Michigan senior faculty, associate or full professors
  • Holders of medical degrees (an M.D. or M.D./Ph.D.)
  • Physician-scientists, individuals who are conducting basic research while maintaining an active clinical practice.
  • Scientists whose research focuses on translational research

 

Taubman Scholar Grant Application Form

 

Once an application is received, it will be reviewed by the Director of the Taubman Institute before being submitted to the Taubman Institute Scientific Advisory Board for evaluation. The advisory board, composed of leading figures in the field of medical research, makes funding recommendations to the Director and to member of the Governing Council of the Taubman Institute, who possess the ultimate grant-making authority.

The criteria for making such decisions include:

  • Quality and scope of the proposed research from applicants who meet all eligibility requirements
  • Translational nature of the proposed research
  • The “high risk, high reward” nature of the proposed research, which would render it unlikely to receive funding from traditional sources of funding
  • Its alignment with the current scientific objectives of the Institute, as determined by the Director and Governing Council

Each new Taubman Scholar is responsible for opening an account in his or her Medical School department to which the grant funding will be transferred. It is the responsibility of that department to monitor all expenses for which this grant is used to make certain that they are in accordance with all University of Michigan policies and regulations.

Taubman Scholars are required to keep the Director of the Institute, the Scientific Advisory Board and the Governing Council informed about the progress of their research. At a minimum, this includes an annual report setting forth the research plan, progress on the plan, any findings to date, any publications based on this research, any issues that may arise, and any other relevant material. Each year, the Scientific Advisory Board will evaluate these progress reports and alert the Director of the Institute and the Governing Council if there are any concerns related to a Scholar’s research, including deviance from the research proposal and lack of reasonable progress.

In addition to conducting research, Taubman Scholars are expected to participate in the seminars, lectures, symposia and other programming of the Taubman Institute. They are also expected to participate in the public engagement, community education and development activities of the organization.

 

Emerging Scholars Grants

The Emerging Scholars Program provides support for physician-scientists on the U-M faculty who are in the early stages of their research careers. This program offers an opportunity for these researchers to establish their credentials in order to secure traditional funding in the future.

Eligibility is restricted to:

  • University of Michigan junior faculty, normally assistant professors
  • Holders of a medical degree (an M.D. or M.D./Ph.D.)
  • Physician-scientists, individuals who are conducting basic research while maintaining an active clinical practice.
  • Scientists whose research focuses on translational research

The term of the grant is three years, and the amount of funding is $50,000 per year.

Funding for the Emerging Scholars Program has come primarily from private philanthropy. In each instance, the donor or donors have expressed an interest in a certain field of research. Because of the rich talent base of physician-researchers at the University of Michigan, the Institute has been able to fulfill each request with a suitable candidate.

The Institute has identified potential Emerging Scholars by issuing a request for applications to current Taubman Institute Scholars, U-M Medical School department chairs and the associate chairs of research of those departments. However, it will accept applications electronically at any time. 

 

Emerging Scholar Grant Application Form

 

Once an application is received, it will be reviewed by the Director of the Taubman Institute before being submitted to the Taubman Institute Scientific Advisory Board for evaluation. The advisory board, composed of leading figures in the field of medical research, makes funding recommendations to the Director and to member of the Governing Council of the Taubman Institute, who possess the ultimate grant-making authority.

The criteria for making such decisions include:

  • Quality and scope of the proposed research from applicants who meet all eligibility requirements
  • Translational nature of the proposed research
  • The “high risk, high reward” nature of the proposed research, which would render it unlikely to receive funding from traditional sources of funding
  • The proposed research's alignment with the current scientific objectives of the Institute, as determined by the Director and Governing Council
  • The candidate's potential for professional development

Each new Taubman Scholar is responsible for opening an account in his or her Medical School department to which the grant funding will be transferred. It is the responsibility of that department to monitor all expenses for which this grant is used to make certain that they are in accordance with all University of Michigan policies and regulations.

Taubman Scholars are required to keep the Director of the Institute, the Scientific Advisory Board and the Governing Council informed about the progress of their research. At a minimum, this includes an annual report setting forth the research plan, progress on the plan, any findings to date, any publications based on this research, any issues that may arise, and any other relevant material. Each year, the Scientific Advisory Board will evaluate these progress reports and alert the Director of the Institute and the Governing Council if there are any concerns related to a Scholar’s research, including deviance from the research proposal and lack of reasonable progress.

In addition to conducting research, Taubman Scholars are expected to participate in the seminars, lectures, symposia and other programming of the Taubman Institute. They are also expected to participate in the public engagement, community education and development activities of the organization.

The Governing Council may decide to renew an Emerging Scholar grant on an annual basis, with the  recommendation of the Scientific Advisory Board.

Senior Scholars

At its discretion, the Governing Council may appoint a current Taubman Scholar to the role of Senior Scholar at the expiration of his or her grant. This decision will be made pursuant to a recommendation from the Director of the Institute and the Scientific Advisory Board.

The term of the grant is three years, and the amount of funding is $50,000 per year.

The responsibilities of the Taubman Scholars, cited above, also apply to the Senior Scholars

Taubman Scholars interested in being considered as a Senior Scholar should submit an application, at least 3 months prior to the expiration of their Taubman Scholar grant.

Senior Scholar Grant Application Form

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists